M&A
Advent-backed Suven Pharma, Cohance Lifesciences to merge
Private Equity firm Advent International-backed Suven Pharmaceuticals Ltd and Cohance Lifesciences Ltd are to merge their businesses. Both firms are based in Hyderabad. The shareholders of Cohance would be issued shares of Suven at the ratio of 11 shares of Suven for every 295 shares of Cohance. Advent would own about 66.7 % in the combined entity and the rest would be owned by the public shareholders.In December 2022, Advent International acquired a 50.1 % stake in Suven Pharma from the Jasti family for INR 6,313 crore
Want to receive such news items in your inbox? Click Here to sign up for a trial.
